Fisher & Paykel Healthcare (ASX: FPH) — Stock Profile

Fisher & Paykel Healthcare Corporation Limited designs, manufactures, markets, and sells medical device products and systems across North America, Europe, the Asia Pacific, and other international markets. The company serves patients requiring acute and chronic respiratory care, surgical support, and treatment of obstructive sleep apnea in both hospital and home settings.

Its product range spans two broad areas, hospital and homecare, with hospital offerings covering adult respiratory care through the Airvo system, Optiflow nasal high flow therapy, invasive and noninvasive ventilation, as well as infant respiratory care through resuscitation, CPAP therapy, and nasal high flow therapy products, alongside humidification products, breathing circuits, chambers, masks, nasal cannulas, and surgical interfaces. The homecare segment includes masks, CPAP devices, humidifiers, and software and data management products for patients managing conditions such as obstructive sleep apnea outside of clinical settings. Founded in 1934, the company is headquartered in Auckland, New Zealand.